ENDRA Life Sciences (NDRA) Change in Inventory (2016 - 2024)

ENDRA Life Sciences has disclosed Change in Inventory across 9 years of filings, most recently posting -$329476.0 for Q4 2024.

• In Q4 2024, Change in Inventory fell 10154.2% year-over-year to -$329476.0; the TTM figure through Jun 2025 stood at -$329476.0 (down 439.59% YoY), while the FY2024 annual figure was -$235731.0, down 302.88% from the prior year.
• Change in Inventory slipped to -$329476.0 in Q4 2024, from -$138046.0 in the prior quarter.
• Over the last five years, Change in Inventory for NDRA reached as high as $2.7 million in Q4 2022 and fell as low as -$1.7 million in Q2 2022.
• The 5-year median for Change in Inventory is $19881.5 (2020), against an average of $133985.4.
• The widest YoY moves for Change in Inventory: up 4867.14% in 2020, down 4812400.0% in 2020.
• A 5-year view of Change in Inventory shows it stood at $685944.0 in 2020, then jumped by 134.0% to $1.6 million in 2021, then surged by 68.82% to $2.7 million in 2022, then tumbled by 99.88% to $3277.0 in 2023, then plunged by 10154.2% to -$329476.0 in 2024.
• According to Business Quant data, Change in Inventory over the past three periods registered -$329476.0, -$138046.0, and $231791.0 for Q4 2024, Q2 2024, and Q1 2024 respectively.